Morenzo Abadi Perkasa Tbk. vs Merck Tbk. — how do they compare? Morenzo Abadi Perkasa Tbk. trades at Rp68 (market cap 149.22B, 1.56M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Merck Tbk. is far larger — about 11.4× Morenzo Abadi Perkasa Tbk.'s market cap, and Morenzo Abadi Perkasa Tbk. is more actively traded (1.56M versus 21.9K). Which is the better fit depends on your goals.
| ENZO | MERK | |
|---|---|---|
Market Cap | 149.22B | 1.7T |
Volume | 1.56M | 21.9K |
Lot | 15.6K | 219 |
Turnover | 106.21M | 83.99M |
Average Price | 68.07 | 3,834.93 |
Value | 106.21M | 83.99M |
Indicative Equilibrium Price | 69 | 3,850 |
Indicative Equilibrium Volume | 66K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →